back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-19 19:28 Tx date 2024-03-19 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+100,000 vol $0.035 each |
2,638,500 | |
| Filed 2024-03-18 10:16 Tx date 2024-03-18 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+150,000 vol $0.035 each |
2,538,500 | |
| Filed 2024-03-15 16:30 Tx date 2024-03-15 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540.00
+18,000 vol $0.03 each |
2,388,500 | |
| Filed 2024-03-15 15:36 Tx date 2024-03-15 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,120
+304,000 vol $0.03 each |
2,370,500 | |
| Filed 2024-03-15 15:31 Tx date 2024-03-15 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,620
+254,000 vol $0.03 each |
||
| Filed 2024-01-05 12:50 Tx date 2024-01-02 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,650,000 | |
| Filed 2024-01-04 16:48 Tx date 2024-01-02 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+400,000 vol $0.05 each |
1,650,000 | |
| Filed 2024-01-04 16:41 Tx date 2024-01-02 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+400,000 vol $0.05 each |
1,400,000 | |
| Filed 2024-01-04 16:37 Tx date 2024-01-02 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+2,000,000 vol $0.05 each |
16,500,000 | |
| Filed 2024-01-04 16:36 Tx date 2024-01-02 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+2,000,000 vol $0.05 each |
||
| Filed 2024-01-04 16:35 Tx date 2022-11-29 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-32,500
-100,000 vol $0.325 each |
14,500,000 | |
| Filed 2024-01-04 16:34 Tx date 2022-11-01 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-50,000
-250,000 vol $0.20 each |
14,600,000 | |
| Filed 2024-01-04 16:31 Tx date 2024-01-02 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+2,000,000 vol $0.05 each |
||
| Filed 2023-10-31 10:40 Tx date 2023-04-14 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-2,000,000 vol |
0 | |
| Filed 2021-11-29 18:16 Tx date 2021-11-29 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$42,000
+150,000 vol $0.28 each |
650,000 | |
| Filed 2021-11-29 18:16 Tx date 2021-11-29 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-150,000 vol |
1,000,000 | |
| Filed 2021-09-08 14:26 Tx date 2021-09-08 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,000
+25,000 vol $0.48 each |
2,066,500 | |
| Filed 2021-09-07 10:34 Tx date 2021-09-07 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,575
+45,000 vol $0.435 each |
2,041,500 | |
| Filed 2021-09-03 15:43 Tx date 2021-09-03 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Holder: Margaret Lindzon TFSA (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,706
+52,000 vol $0.3982 each |
52,000 | |
| Filed 2021-09-03 15:34 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Holder: Margaret Lindzon TFSA (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-03 12:25 Tx date 2021-09-03 |
$RVV
Revive Therapeutics Ltd. |
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,250
+25,000 vol $0.41 each |
2,120,000 | |
| Filed 2021-09-02 13:50 Tx date 2021-09-02 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,000
+50,000 vol $0.38 each |
1,996,500 | |
| Filed 2021-08-23 14:13 Tx date 2021-08-23 |
$RVV
Revive Therapeutics Ltd. |
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+50,000 vol $0.42 each |
2,095,000 | |
| Filed 2021-07-30 16:22 Tx date 2021-07-30 |
$RVV
Revive Therapeutics Ltd. |
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,896
+45,000 vol $0.51 each |
2,045,000 | |
| Filed 2021-06-25 16:10 Tx date 2021-06-24 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$21,000
+300,000 vol $0.07 each |
500,000 | |
| Filed 2021-06-25 16:04 Tx date 2021-06-24 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-300,000 vol |
1,150,000 | |
| Filed 2021-06-24 08:42 Tx date 2021-06-21 |
$RVV
Revive Therapeutics Ltd. |
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+500,000 vol $0.60 each |
500,000 | |
| Filed 2021-06-24 08:42 Tx date 2020-03-05 |
$RVV
Revive Therapeutics Ltd. |
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-22 16:12 Tx date 2021-06-21 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+750,000 vol $0.60 each |
1,250,000 | |
| Filed 2021-06-22 10:53 Tx date 2021-06-21 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
1,250,000 | |
| Filed 2021-06-22 10:51 Tx date 2021-06-21 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
1,450,000 | |
| Filed 2021-06-22 10:48 Tx date 2021-06-21 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,000,000 vol |
14,850,000 | |
| Filed 2021-03-04 18:52 Tx date 2021-03-04 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,000
+50,000 vol $0.38 each |
1,946,500 | |
| Filed 2021-03-04 18:51 Tx date 2021-03-04 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+10,000 vol $0.40 each |
1,896,500 | |
| Filed 2021-03-04 18:50 Tx date 2021-03-04 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,800
+40,000 vol $0.395 each |
1,886,500 | |
| Filed 2021-03-04 18:49 Tx date 2021-03-04 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+10,000 vol $0.40 each |
||
| Filed 2021-03-04 18:49 Tx date 2021-03-04 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,875
+25,000 vol $0.395 each |
||
| Filed 2021-03-04 18:48 Tx date 2021-03-04 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+10,000 vol $0.40 each |
||
| Filed 2021-03-04 18:47 Tx date 2021-03-04 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,875
+25,000 vol $0.395 each |
||
| Filed 2021-03-03 16:15 Tx date 2021-03-03 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,675
+15,000 vol $0.445 each |
1,846,500 | |
| Filed 2021-03-03 16:15 Tx date 2021-03-03 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+20,000 vol $0.45 each |
1,831,500 | |
| Filed 2021-03-03 16:14 Tx date 2021-03-03 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+25,000 vol $0.44 each |
1,811,500 | |
| Filed 2021-03-02 14:12 Tx date 2021-03-02 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,000
+40,000 vol $0.475 each |
1,786,500 | |
| Filed 2021-02-23 12:25 Tx date 2021-02-18 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$14,000
+200,000 vol $0.07 each |
200,000 | |
| Filed 2021-02-23 12:24 Tx date 2021-02-18 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-200,000 vol |
700,000 | |
| Filed 2021-02-22 18:36 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-10 12:07 Tx date 2020-08-05 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,980,000
+6,000,000 vol $0.33 each |
10,850,000 | |
| Filed 2020-06-04 08:38 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Herman, Joshua Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,334 | ||
| Filed 2020-06-04 08:36 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Herman, Joshua Jonathan
4 - Director of Issuer
Holder: Carly Herman (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2020-06-04 08:33 Tx date 2019-12-27 |
$RVV
Revive Therapeutics Ltd. |
Herman, Joshua Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+500,000 vol $0.07 each |
625,334 | |
| Filed 2020-06-04 08:32 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Herman, Joshua Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-26 11:05 Tx date 2020-03-05 |
$RVV
Revive Therapeutics Ltd. |
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2020-05-25 17:35 Tx date 2020-05-25 |
$RVV
Revive Therapeutics Ltd. |
Marrelli, Carmelo
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
570,000 | |
| Filed 2020-05-25 17:31 Tx date 2020-05-25 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,000,000 vol |
4,850,000 | |
| Filed 2020-04-22 13:26 Tx date 2020-04-15 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,500,000 vol |
2,000,000 | |
| Filed 2020-04-22 13:24 Tx date 2020-04-15 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+1,500,000 vol $0.05 each |
2,000,000 | |
| Filed 2020-03-19 07:31 Tx date 2020-03-18 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+500,000 vol |
500,000 | |
| Filed 2020-03-19 07:29 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-19 07:29 Tx date 2020-03-18 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2020-03-19 07:26 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-11 11:04 Tx date 2020-02-07 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-81,250
-250,000 vol $0.325 each |
1,850,000 | |
| Filed 2020-02-03 14:32 Tx date 2020-02-03 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+32,000 vol $0.05 each |
1,746,500 | |
| Filed 2020-02-03 14:31 Tx date 2020-02-03 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.00
+8,000 vol $0.045 each |
1,714,500 | |
| Filed 2020-01-08 11:36 Tx date 2020-01-07 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-600,000 vol |
0 | |
| Filed 2020-01-08 11:34 Tx date 2020-01-07 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-275,000 vol |
0 | |
| Filed 2020-01-06 14:30 Tx date 2020-01-06 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,200
+40,000 vol $0.055 each |
1,706,500 | |
| Filed 2020-01-02 11:04 Tx date 2020-01-02 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,200
+70,000 vol $0.06 each |
1,666,500 | |
| Filed 2019-12-30 23:15 Tx date 2019-12-27 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2019-12-30 23:12 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-12-30 17:39 Tx date 2019-12-27 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,500,000 vol |
2,100,000 | |
| Filed 2019-12-30 17:37 Tx date 2019-12-27 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2019-12-30 17:36 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-12-30 17:29 Tx date 2019-12-27 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
900,000 | |
| Filed 2019-12-30 10:49 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2019-12-20 14:45 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Holder: Margaret Lindzon RESP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,700 | ||
| Filed 2019-12-20 14:44 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Holder: Aaron Lindzon (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2019-12-20 14:44 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
43,000 | ||
| Filed 2019-12-18 17:38 Tx date 2019-12-18 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,596,500 | ||
| Filed 2019-06-19 14:50 Tx date 2019-06-19 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
+24,000 vol |
1,154,000 | |
| Filed 2019-06-19 14:40 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. (formerly, Mercury Capital II Limited) |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Rangercap Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$67,500
+225,000 vol $0.30 each |
225,000 | |
| Filed 2019-06-19 14:35 Tx date 2018-06-18 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-125,000 vol |
0 | |
| Filed 2014-01-09 21:28 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. (formerly, Mercury Capital II Limited) |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Rangercap Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$75,000
+250,000 vol $0.30 each |
||
| Filed 2017-12-22 Tx date 2017-12-19 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,550
-18,500 vol $0.30 each |
6,795,100 | |
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,410
-11,000 vol $0.31 each |
6,813,600 | |
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,250
-50,000 vol $0.305 each |
6,824,600 | |
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$22,500
+125,000 vol $0.18 each |
6,874,600 | |
| Filed 2017-12-22 Tx date 2017-12-20 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,850
-29,500 vol $0.30 each |
6,749,600 | |
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-125,000 vol |
0 | |
| Filed 2017-12-22 Tx date 2017-12-19 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,960
-16,000 vol $0.31 each |
6,779,100 | |
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,750
-125,000 vol $0.31 each |
1,130,000 | |
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$22,500
+125,000 vol $0.18 each |
1,255,000 | |
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-125,000 vol |
0 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-206,800
-940,000 vol $0.22 each |
1,130,000 | |
| Filed 2017-04-12 Tx date 2017-04-10 |
$RVV
Revive Therapeutics Ltd. |
Marrelli, Carmelo
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
70,000 | |
| Filed 2017-04-12 Tx date 2017-04-10 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
275,000 | |
| Filed 2017-04-12 Tx date 2017-04-10 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
600,000 | |
| Filed 2017-04-12 Tx date 2017-04-10 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
400,000 | |
| Filed 2017-04-12 Tx date 2017-04-10 |
$RVV
Revive Therapeutics Ltd. |
Incledon, Beverly James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
45,000 | |
| Filed 2017-04-12 Tx date 2017-04-10 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
315,375 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Holder: Rangercap Inc. (Control or Direction)
|
Rights
58 - Expiration of rights
|
-250,000 vol |
0 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+125,000 vol |
125,000 | |
| Filed 2016-06-20 Tx date 2013-05-24 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Rights
58 - Expiration of rights
|
-991,666 vol |
0 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Holder: NBCN Inc. ITF Carlo Sansalone (Control or Direction)
|
Rights
58 - Expiration of rights
|
-460,000 vol |
0 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
2,070,000 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+125,000 vol |
125,000 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-250,000 vol |
991,666 | |
| Filed 2016-06-20 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spouse (Indirect Ownership)
|
Rights
58 - Expiration of rights
|
-121,000 vol |
0 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
58 - Expiration of rights
|
-6,249,600 vol |
0 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-250,000 vol |
6,249,600 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
6,749,600 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
1,491,666 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+125,000 vol |
125,000 | |
| Filed 2016-06-20 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Rights
58 - Expiration of rights
|
-1,570,000 vol |
0 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-250,000 vol |
1,570,000 | |
| Filed 2016-05-24 Tx date 2013-05-24 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Holder: NBCN Inc. ITF Carlo Sansalone (Control or Direction)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+1,820,000 vol |
1,820,000 | |
| Filed 2016-05-24 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Holder: Rangercap Inc. (Control or Direction)
|
Rights
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+6,499,600 vol |
6,499,600 | |
| Filed 2016-05-24 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spouse (Control or Direction)
|
Rights
56 - Grant of rights
|
+121,000 vol |
121,000 | |
| Filed 2016-05-24 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spouse (Control or Direction)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-24 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Holder: Rangercap Inc. (Control or Direction)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Holder: NBCN Inc. ITF Carlo Sansalone (Control or Direction)
|
Rights
56 - Grant of rights
|
+460,000 vol |
460,000 | |
| Filed 2016-05-24 Tx date 2013-05-24 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+1,241,666 vol |
1,241,666 | |
| Filed 2015-09-29 Tx date 2015-09-21 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$740.00
+2,000 vol $0.37 each |
1,223,666 | |
| Filed 2015-09-29 Tx date 2015-09-21 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,680
+4,000 vol $0.42 each |
1,227,666 | |
| Filed 2015-09-29 Tx date 2015-09-21 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,300
+14,000 vol $0.45 each |
1,241,666 | |
| Filed 2015-06-15 Tx date 2015-06-12 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-140,000
-200,000 vol $0.70 each |
1,820,000 | |
| Filed 2015-05-25 Tx date 2015-05-15 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-500,000 vol |
6,499,600 | |
| Filed 2015-04-30 Tx date 2015-04-22 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-1,500,000 vol |
6,999,600 | |
| Filed 2015-04-30 Tx date 2015-04-22 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+1,500,000 vol |
2,020,000 |